1258226

Jubilant Draximage (USA) Inc. — FEI 3014118270

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 19, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Yardley, PA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)